The Effect of Intravenous Dexmedetomidine on the Duration of Spinal Block and Postoperative Pain in Women Undergoing Cesarean Section

The Effect of Intravenous Dexmedetomidine on the Duration of Spinal Block and Postoperative Pain in Women Undergoing Cesarean Section - Dex-Ces

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000058861

Enrollment

Registered

2025-08-22

Start date

2018-12-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

it is thesis of pharmacy student that was done at the university hospital

Interventions

Participants were randomized into two groups using a computer generated sequence: Dexmedetomidine group (n=25): Received 12.5 mg of 0.5% hyperbaric bupivacaine intrathecally and an intravenous bolu

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists physical status 1 and 2. Age 18-40 years. Full term pregnancy (37-40 weeks).

Exclusion criteria

Exclusion criteria: History of adverse reactions to local anesthetics or dexmedetomidine. Contraindications to spinal anesthesia. Emergency cesarean sections.

Design outcomes

Primary

Measure	Time frame
postoperative pain intensity measured by Visual Analog Scale (VAS) scores at 2, 6, 12, and 24 hours after cesarean section.	—

Countries

Asia(except Japan)

Contacts

Public Contactseyed sohrevardi

faculty of Pharmacy pharmacotherapy department

smsohrevardi@yahoo.com+989134512422

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026